We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Medical Stocks Lagging AnaptysBio (ANAB) This Year?
Read MoreHide Full Article
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is AnaptysBio, Inc. (ANAB - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
AnaptysBio, Inc. is one of 1010 individual stocks in the Medical sector. Collectively, these companies sit at #2 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. AnaptysBio, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for ANAB's full-year earnings has moved 24% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the latest available data, ANAB has gained about 27.3% so far this year. At the same time, Medical stocks have lost an average of 1.6%. As we can see, AnaptysBio, Inc. is performing better than its sector in the calendar year.
Inspire Medical Systems (INSP - Free Report) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 1.7%.
Over the past three months, Inspire Medical Systems' consensus EPS estimate for the current year has increased 49.6%. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, AnaptysBio, Inc. belongs to the Medical - Biomedical and Genetics industry, which includes 512 individual stocks and currently sits at #70 in the Zacks Industry Rank. Stocks in this group have lost about 10.7% so far this year, so ANAB is performing better this group in terms of year-to-date returns.
On the other hand, Inspire Medical Systems belongs to the Medical Info Systems industry. This 39-stock industry is currently ranked #56. The industry has moved -3.9% year to date.
Investors with an interest in Medical stocks should continue to track AnaptysBio, Inc. and Inspire Medical Systems. These stocks will be looking to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Are Medical Stocks Lagging AnaptysBio (ANAB) This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is AnaptysBio, Inc. (ANAB - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
AnaptysBio, Inc. is one of 1010 individual stocks in the Medical sector. Collectively, these companies sit at #2 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. AnaptysBio, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for ANAB's full-year earnings has moved 24% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the latest available data, ANAB has gained about 27.3% so far this year. At the same time, Medical stocks have lost an average of 1.6%. As we can see, AnaptysBio, Inc. is performing better than its sector in the calendar year.
Inspire Medical Systems (INSP - Free Report) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 1.7%.
Over the past three months, Inspire Medical Systems' consensus EPS estimate for the current year has increased 49.6%. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, AnaptysBio, Inc. belongs to the Medical - Biomedical and Genetics industry, which includes 512 individual stocks and currently sits at #70 in the Zacks Industry Rank. Stocks in this group have lost about 10.7% so far this year, so ANAB is performing better this group in terms of year-to-date returns.
On the other hand, Inspire Medical Systems belongs to the Medical Info Systems industry. This 39-stock industry is currently ranked #56. The industry has moved -3.9% year to date.
Investors with an interest in Medical stocks should continue to track AnaptysBio, Inc. and Inspire Medical Systems. These stocks will be looking to continue their solid performance.